Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP800930.RAYXejQn27v2ChgU41oEiORuAavHUVUoA4Bh4LQb_NJ88130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP800930.RAYXejQn27v2ChgU41oEiORuAavHUVUoA4Bh4LQb_NJ88130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP800930.RAYXejQn27v2ChgU41oEiORuAavHUVUoA4Bh4LQb_NJ88130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP800930.RAYXejQn27v2ChgU41oEiORuAavHUVUoA4Bh4LQb_NJ88130_provenance.
- NP800930.RAYXejQn27v2ChgU41oEiORuAavHUVUoA4Bh4LQb_NJ88130_assertion description "[Accordingly, beneficial pleiotropic effects of statins on coronary artery disease may be attributable, in part, to attenuation of overexpression of PAI-1 mediated by the 3'-UTR in syndromes of insulin resistance (such as the metabolic syndrome) and type 2 diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP800930.RAYXejQn27v2ChgU41oEiORuAavHUVUoA4Bh4LQb_NJ88130_provenance.
- NP800930.RAYXejQn27v2ChgU41oEiORuAavHUVUoA4Bh4LQb_NJ88130_assertion evidence source_evidence_literature NP800930.RAYXejQn27v2ChgU41oEiORuAavHUVUoA4Bh4LQb_NJ88130_provenance.
- NP800930.RAYXejQn27v2ChgU41oEiORuAavHUVUoA4Bh4LQb_NJ88130_assertion SIO_000772 20299979 NP800930.RAYXejQn27v2ChgU41oEiORuAavHUVUoA4Bh4LQb_NJ88130_provenance.
- NP800930.RAYXejQn27v2ChgU41oEiORuAavHUVUoA4Bh4LQb_NJ88130_assertion wasDerivedFrom befree-2016 NP800930.RAYXejQn27v2ChgU41oEiORuAavHUVUoA4Bh4LQb_NJ88130_provenance.
- NP800930.RAYXejQn27v2ChgU41oEiORuAavHUVUoA4Bh4LQb_NJ88130_assertion wasGeneratedBy ECO_0000203 NP800930.RAYXejQn27v2ChgU41oEiORuAavHUVUoA4Bh4LQb_NJ88130_provenance.
- befree-2016 importedOn "2016-02-19" NP800930.RAYXejQn27v2ChgU41oEiORuAavHUVUoA4Bh4LQb_NJ88130_provenance.